Edition:
India

Enanta Pharmaceuticals Inc (ENTA.OQ)

ENTA.OQ on NASDAQ Stock Exchange Global Select Market

65.78USD
2:29am IST
Change (% chg)

$3.02 (+4.81%)
Prev Close
$62.76
Open
$63.24
Day's High
$66.00
Day's Low
$62.82
Volume
92,272
Avg. Vol
71,664
52-wk High
$66.00
52-wk Low
$25.92

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 75.93 1.784
Jun '17 7.51 -0.442
Mar '17 8.96 -0.283
Dec 10.42 -0.262
FY 2016 Sep '16 12.84 -0.095
Jun '16 13.98 -0.057
Mar '16 13.00 -0.087
Dec 48.44 1.359
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 3 17.80 21.00 12.93 --
Quarter Ending Jun-18 3 18.74 21.00 15.24 --
Year Ending Sep-18 4 85.94 97.00 69.44 --
Year Ending Sep-19 2 103.79 124.00 83.57 --
Earnings (per share)
Quarter Ending Mar-18 2 -0.50 -0.24 -0.75 --
Quarter Ending Jun-18 2 -0.57 -0.37 -0.77 --
Year Ending Sep-18 4 -1.24 -0.46 -2.36 --
Year Ending Sep-19 2 -0.82 -0.62 -1.03 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % -45.13 40.17 16.08
EPS (TTM) % -72.47 -- -3.14
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Enanta Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 13.92 10.00 78 --
13 Week 36.10 29.47 86 --
26 Week 63.09 50.69 89 --
52 Week 87.21 58.68 88 --
YTD 45.07 27.41 72 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 68.02%
# of Holders: 193
Total Shares Held: 13,010,373
3 Mo. Net Change: -133,860
# New Positions: 5
# Closed Positions: 0
# Increased Positions: 11
# Reduced Positions: 4
# Net Buyers: 7
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.